Survival of lung cancer patients in a resource-limited country

Aim: Data on lung cancer survival are lacking in developing countries. Our objectives were to describe the survival of our lung cancer patients and to determine independent prognostic factors affecting survival. Method: All patients diagnosed with lung cancer from August 2007 to August 2010 were...

Full description

Bibliographic Details
Main Authors: How, Soon Hin, Ng, Teck Han, Kuan, Yeh Chunn, Ab Rahman, Jamalludin, Fauzi, Abdul Rani
Format: Article
Language:English
English
English
Published: John Wiley & Sons 2015
Subjects:
Online Access:http://irep.iium.edu.my/34285/3/lung_cancer_acceptance_e_mail.jpeg
http://irep.iium.edu.my/34285/7/Lung_cancer_AJCO.pdf
http://irep.iium.edu.my/34285/10/Surviva_of_lung_cancer_patients.pdf
_version_ 1825647755178016768
author How, Soon Hin
Ng, Teck Han
Kuan, Yeh Chunn
Ab Rahman, Jamalludin
Fauzi, Abdul Rani
author_facet How, Soon Hin
Ng, Teck Han
Kuan, Yeh Chunn
Ab Rahman, Jamalludin
Fauzi, Abdul Rani
author_sort How, Soon Hin
collection IIUM
description Aim: Data on lung cancer survival are lacking in developing countries. Our objectives were to describe the survival of our lung cancer patients and to determine independent prognostic factors affecting survival. Method: All patients diagnosed with lung cancer from August 2007 to August 2010 were recruited from a single referral hospital of the state of Pahang, Malaysia. Detailed demographic data, ECOG (Eastern Cooperation Oncology Group) performance status, stage of disease and treatment were recorded. The date of histology or cytology confirmation was used as the date of entry. Survival time was calculated from the date of entry to the date of death. Results: One hundred forty-nine patients were included for survival analysis. The median age was 62 years and patients were predominantly males (78%) and smokers (78%). The majority had non-small cell lung cancer (NSCLC) (94%); only six patients (4%) had small cell lung cancer. All patients presented with stage 3 or stage 4 disease. Overall median survival was 18 weeks. “No definitive treatment” and “ECOG 3–4” were the significant independent predictors of death, with the hazard ratios of 2.1 (95% confidence interval [CI] 1.4, 3.0) and 1.6 (95% CI 1.1, 2.3) times, respectively. Among NSCLC patients on treatment, 1- and 2-year survival rates were 27% and 15%, respectively. Conclusion: The majority of lung cancer patients in Pahang presented with advanced disease. No definitive treatment and ECOG 3–4 were independent poor prognostic factors.
first_indexed 2024-03-05T23:22:17Z
format Article
id oai:generic.eprints.org:34285
institution International Islamic University Malaysia
language English
English
English
last_indexed 2024-03-05T23:22:17Z
publishDate 2015
publisher John Wiley & Sons
record_format dspace
spelling oai:generic.eprints.org:342852016-03-11T09:09:50Z http://irep.iium.edu.my/34285/ Survival of lung cancer patients in a resource-limited country How, Soon Hin Ng, Teck Han Kuan, Yeh Chunn Ab Rahman, Jamalludin Fauzi, Abdul Rani R Medicine (General) Aim: Data on lung cancer survival are lacking in developing countries. Our objectives were to describe the survival of our lung cancer patients and to determine independent prognostic factors affecting survival. Method: All patients diagnosed with lung cancer from August 2007 to August 2010 were recruited from a single referral hospital of the state of Pahang, Malaysia. Detailed demographic data, ECOG (Eastern Cooperation Oncology Group) performance status, stage of disease and treatment were recorded. The date of histology or cytology confirmation was used as the date of entry. Survival time was calculated from the date of entry to the date of death. Results: One hundred forty-nine patients were included for survival analysis. The median age was 62 years and patients were predominantly males (78%) and smokers (78%). The majority had non-small cell lung cancer (NSCLC) (94%); only six patients (4%) had small cell lung cancer. All patients presented with stage 3 or stage 4 disease. Overall median survival was 18 weeks. “No definitive treatment” and “ECOG 3–4” were the significant independent predictors of death, with the hazard ratios of 2.1 (95% confidence interval [CI] 1.4, 3.0) and 1.6 (95% CI 1.1, 2.3) times, respectively. Among NSCLC patients on treatment, 1- and 2-year survival rates were 27% and 15%, respectively. Conclusion: The majority of lung cancer patients in Pahang presented with advanced disease. No definitive treatment and ECOG 3–4 were independent poor prognostic factors. John Wiley & Sons 2015-09-01 Article PeerReviewed application/pdf en http://irep.iium.edu.my/34285/3/lung_cancer_acceptance_e_mail.jpeg application/pdf en http://irep.iium.edu.my/34285/7/Lung_cancer_AJCO.pdf application/pdf en http://irep.iium.edu.my/34285/10/Surviva_of_lung_cancer_patients.pdf How, Soon Hin and Ng, Teck Han and Kuan, Yeh Chunn and Ab Rahman, Jamalludin and Fauzi, Abdul Rani (2015) Survival of lung cancer patients in a resource-limited country. Asia-Pacific Journal of Clinical Oncology, 11 (3). pp. 221-227. ISSN 1743-7563 http://onlinelibrary.wiley.com/journal/10.1111/%28ISSN%291743-7563 10.1111/ajco.12179
spellingShingle R Medicine (General)
How, Soon Hin
Ng, Teck Han
Kuan, Yeh Chunn
Ab Rahman, Jamalludin
Fauzi, Abdul Rani
Survival of lung cancer patients in a resource-limited country
title Survival of lung cancer patients in a resource-limited country
title_full Survival of lung cancer patients in a resource-limited country
title_fullStr Survival of lung cancer patients in a resource-limited country
title_full_unstemmed Survival of lung cancer patients in a resource-limited country
title_short Survival of lung cancer patients in a resource-limited country
title_sort survival of lung cancer patients in a resource limited country
topic R Medicine (General)
url http://irep.iium.edu.my/34285/3/lung_cancer_acceptance_e_mail.jpeg
http://irep.iium.edu.my/34285/7/Lung_cancer_AJCO.pdf
http://irep.iium.edu.my/34285/10/Surviva_of_lung_cancer_patients.pdf
work_keys_str_mv AT howsoonhin survivaloflungcancerpatientsinaresourcelimitedcountry
AT ngteckhan survivaloflungcancerpatientsinaresourcelimitedcountry
AT kuanyehchunn survivaloflungcancerpatientsinaresourcelimitedcountry
AT abrahmanjamalludin survivaloflungcancerpatientsinaresourcelimitedcountry
AT fauziabdulrani survivaloflungcancerpatientsinaresourcelimitedcountry